認知症治療の世界市場レポート 2025年

認知症治療の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.7%で291億2,000万米ドルに成長します。予測期間中の成長は、ヘルスケア支出の増加、慢性疾患の有病率の上昇、臨床試験の増加、製薬業界の成長、アルツハイマー病罹患率の上昇などの要因に起因すると考えられます。予測期間における主な動向としては、科学研究の発展、診断と治療管理のための人工知能と機械学習の利用、新薬と治療法の開発、バイオテクノロジーへの投資の増加、個別化治療アプローチの進歩などが挙げられます。

神経変性疾患の有病率の上昇は、今後数年間の認知症治療市場の成長を促進すると予想されます。神経変性疾患は、神経細胞の進行性の変性と喪失を伴い、運動、認知、またはその両方に障害をもたらします。このような神経変性疾患の増加は、平均寿命の延長がアルツハイマー病やパーキンソン病などの加齢に関連する疾患のリスクを高め、加齢が主な要因となっていることから、高齢化社会に大きく起因しています。神経変性疾患に対する理解が深まれば、より正確な診断と的を絞った治療が可能になり、症状に合わせた効果的なアプローチが可能になるため、認知症治療が強化されます。例えば、アルツハイマー病協会が2024年4月に発表した報告書によると、65歳以上のアメリカ人のうち約690万人がアルツハイマー型認知症に罹患しており、この数は2060年までに2倍の1,380万人になると予測されています。その結果、神経変性疾患の有病率の増加が、認知症治療市場の成長を大きく牽引することになります。

認知症治療分野の主要企業は、複雑で多様なシナリオを再現するバーチャルリアリティ（VR）トレーニングプログラムなど、高度な技術ソリューションの開発に注力しています。VRトレーニングプログラムは、没入型のコンピュータ生成体験であり、制御されたインタラクティブで現実的な仮想環境でスキルを練習し磨く機会を個人に提供します。例えば、2024年9月、日本のOtsuka Pharmaceutical Co. Ltd.は、日本の医療技術企業である株式会社Jolly Good Inc.と協力し、認知症ケアに特化したVRトレーニングプログラム「FACEDUO」を発表しました。医療専門家が監修したこの対話型VRツールは、家族を含む介護者が認知症の人の感情や行動を理解するのを支援します。実際の状況をシミュレートすることで、介護者は認知症患者特有のニーズにより効果的に対応できるようになります。このプログラムの主な目的は、介護能力を高め、より効果的な支援のための共感を育むことです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の認知症治療のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の認知症治療市場：成長率分析
• 世界の認知症治療市場の実績：規模と成長、2019～2024年
• 世界の認知症治療市場の予測：規模と成長、2024～2029年、2034年
• 世界の認知症治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の認知症治療市場：治療タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 抗精神病薬
• コリンエステラーゼ阻害剤
• メマンチン
• その他
• 世界の認知症治療市場：適応症別、実績と予測、2019～2024年、2024～2029年、2034年
• アルツハイマー型認知症
• 血管性認知症
• レビー小体型認知症
• 前頭側頭型認知症
• パーキンソン型認知症
• その他
• 世界の認知症治療市場：投与経路別、実績と予測、2019～2024年、2024～2029年、2034年
• 経口
• 経皮パッチ
• 注射剤
• 世界の認知症治療市場：認知症の段階別、実績と予測、2019～2024年、2024～2029年、2034年
• 軽度認知症
• 中等度認知症
• 重度認知症
• 世界の認知症治療市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 小売薬局
• オンライン薬局
• 世界の認知症治療市場：抗精神病薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 非定型抗精神病薬
• 定型抗精神病薬
• 世界の認知症治療市場：コリンエステラーゼ阻害剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ドネペジル
• リバスチグミン
• ガランタミン
• 世界の認知症治療市場：メマンチンのサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• メマンチン単剤療法
• メマンチン併用療法
• 世界の認知症治療市場：その他のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 認知機能向上剤
• NMDA受容体拮抗薬
• 栄養補助食品・ハーブサプリメント
• ホルモン治療
• 幹細胞療法

第7章 地域別・国別分析

• 世界の認知症治療市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の認知症治療市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 認知症治療市場：競合情勢
• 認知症治療市場：企業プロファイル
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Biogen Inc.
• Eisai Co. Ltd.
• Merz Pharmaceuticals GmbH
• Acadia Pharmaceuticals Inc.
• Intra-Cellular Therapies Inc.
• Cerevance Inc.
• Retro Biosciences Inc.
• AviadoBio Ltd.
• MapHabit Inc.
• Neuvivo Inc.
• Harmonic Health Inc.
• Rippl Care Inc.
• Isaac Health Inc.
• EmTech Care Labs Inc.
• LifeBio Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 認知症治療市場2029年：新たな機会を提供する国
• 認知症治療市場2029年：新たな機会を提供するセグメント
• 認知症治療市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Dementia treatment involves a combination of medical, psychological, and supportive approaches aimed at managing symptoms and slowing the progression of the condition, which is characterized by memory loss, cognitive decline, and difficulty with reasoning. Early detection of dementia enables more effective intervention and facilitates the preparation of long-term care plans. Tailored treatment strategies, based on the specific type and stage of dementia, can enhance the quality of life for those affected.

The primary treatment options for dementia include antipsychotics, cholinesterase inhibitors, memantine, and others. Antipsychotic medications are prescribed to manage behavioral and psychological symptoms in dementia patients, such as aggression, agitation, and hallucinations. These medications are used to treat various forms of dementia, including Alzheimer's disease dementia, vascular dementia, Lewy body dementia, frontotemporal dementia, Parkinson's disease dementia, and others. Antipsychotics can be administered via oral tablets, transdermal patches, or injectables, and are used for managing mild, moderate, and severe stages of dementia. They are typically distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

The dementia treatment market research report is one of a series of new reports from The Business Research Company that provides dementia treatment market statistics, including dementia treatment industry global market size, regional shares, competitors with a dementia treatment market share, detailed dementia treatment market segments, market trends and opportunities, and any further data you may need to thrive in the dementia treatment industry. This dementia treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dementia treatment market size has grown strongly in recent years. It will grow from $18.32 billion in 2024 to $20.14 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth during the historic period can be attributed to factors such as the aging population, improved diagnosis rates, greater awareness of dementia, the expansion of healthcare infrastructure, and increased government funding for dementia research and treatment.

The dementia treatment market size is expected to see strong growth in the next few years. It will grow to $29.12 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. The growth during the forecast period can be attributed to factors such as increased healthcare expenditure, a higher prevalence of chronic diseases, more clinical trials, growth in the pharmaceutical industry, and rising rates of Alzheimer's disease. Key trends in the forecast period include advancements in scientific research, the use of artificial intelligence and machine learning for diagnosis and treatment management, the development of new drugs and therapies, increased investment in biotechnology, and progress in personalized treatment approaches.

The rising prevalence of neurodegenerative disorders is expected to drive the growth of the dementia treatment market in the coming years. Neurodegenerative disorders, which involve the progressive degeneration and loss of nerve cells, lead to impairments in movement, cognition, or both. This increase in neurodegenerative disorders is largely attributed to the aging population, as longer life expectancy raises the risk of age-related conditions such as Alzheimer's and Parkinson's disease, with age being the primary contributing factor. A deeper understanding of neurodegenerative disorders enhances dementia treatment by enabling more accurate diagnoses and targeted therapies, allowing for a more personalized and effective approach to managing symptoms. For instance, according to a report published in April 2024 by the Alzheimer's Association, approximately 6.9 million Americans aged 65 and older were affected by Alzheimer's dementia, with projections suggesting this number will double to 13.8 million by 2060. As a result, the growing prevalence of neurodegenerative disorders will significantly drive the growth of the dementia treatment market.

Leading companies in the dementia treatment sector are concentrating on developing advanced technological solutions, such as virtual reality (VR) training programs, to replicate intricate and varied scenarios. VR training programs are immersive, computer-generated experiences that provide individuals with the opportunity to practice and refine their skills in a controlled, interactive, and realistic virtual setting. For example, in September 2024, Otsuka Pharmaceutical Co. Ltd., based in Japan, collaborated with Jolly Good Inc., a medical technology company from Japan, to introduce FACEDUO, a VR training program tailored for dementia care. This interactive VR tool, overseen by medical professionals, assists caregivers, including family members, in understanding the emotions and behaviors of individuals with dementia. By simulating real-life situations, the program enables caregivers to respond more effectively to the specific needs of dementia patients. Its primary goal is to enhance caregiving abilities and foster empathy for more impactful support.

In April 2024, Rippl, a US-based provider specializing in dementia care, acquired Kinto for an undisclosed sum. This acquisition aims to expedite the development of Rippl's dementia care platform by integrating artificial intelligence (AI)-driven solutions to enhance patient care. Kinto, a US-based AI healthcare company, focuses specifically on dementia care.

Major players in the dementia treatment market are Roche Holding AG, AbbVie Inc., Sanofi S.A., Eli Lilly and Company, Amgen Inc., Biogen Inc., Eisai Co. Ltd., Merz Pharmaceuticals GmbH, Acadia Pharmaceuticals Inc., Intra-Cellular Therapies Inc., Cerevance Inc., Retro Biosciences Inc., AviadoBio Ltd., MapHabit Inc., Neuvivo Inc., Harmonic Health Inc., Rippl Care Inc., Isaac Health Inc., EmTech Care Labs Inc., and LifeBio Inc.

North America was the largest region in the dementia treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dementia treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dementia treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dementia treatment market consists of revenues earned by entities by providing services such as medication management, cognitive therapy and stimulation, and behavioral and psychological support. The market value includes the value of related goods sold by the service provider or included within the service offering. The dementia treatment market also includes sales of memory-enhancing medications, nutritional supplements, cognitive stimulation tools, and medical alert systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dementia Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dementia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dementia treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The dementia treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Type: Antipsychotics; Cholinesterase Inhibitors; Memantine; Other Treatment Types
• 2) By Indication: Alzheimer's Disease Dementia; Vascular Dementia; Lewy Body Dementia; Frontotemporal Dementia; Parkinson Disease Dementia; Other Indications
• 3) By Route of Administration: Oral; Transdermal Patch; Injectable
• 4) By Stage of Dementia: Mild Dementia; Moderate Dementia; Severe Dementia
• 5) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
• Subsegments:
• 1) By Antipsychotics: Atypical Antipsychotics; Typical Antipsychotics
• 2) By Cholinesterase Inhibitors: Donepezil; Rivastigmine; Galantamine
• 3) By Memantine: Memantine Monotherapy; Memantine Combination Therapy
• 4) By Other Treatment Types: Cognitive Enhancers; NMDA Receptor Antagonists; Nutritional And Herbal Supplements; Hormonal Treatments; Stem Cell Therapy
• Companies Mentioned: Roche Holding AG; AbbVie Inc.; Sanofi S.A.; Eli Lilly and Company; Amgen Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Dementia Treatment Market Characteristics

3. Dementia Treatment Market Trends And Strategies

4. Dementia Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Dementia Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Dementia Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Dementia Treatment Market Growth Rate Analysis
• 5.4. Global Dementia Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Dementia Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Dementia Treatment Total Addressable Market (TAM)

6. Dementia Treatment Market Segmentation

• 6.1. Global Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antipsychotics
• Cholinesterase Inhibitors
• Memantine
• Other Treatment Types
• 6.2. Global Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease Dementia
• Vascular Dementia
• Lewy Body Dementia
• Frontotemporal Dementia
• Parkinson Disease Dementia
• Other Indications
• 6.3. Global Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Transdermal Patch
• Injectable
• 6.4. Global Dementia Treatment Market, Segmentation By Stage of Dementia, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mild Dementia
• Moderate Dementia
• Severe Dementia
• 6.5. Global Dementia Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• 6.6. Global Dementia Treatment Market, Sub-Segmentation Of Antipsychotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Atypical Antipsychotics
• Typical Antipsychotics
• 6.7. Global Dementia Treatment Market, Sub-Segmentation Of Cholinesterase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Donepezil
• Rivastigmine
• Galantamine
• 6.8. Global Dementia Treatment Market, Sub-Segmentation Of Memantine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Memantine Monotherapy
• Memantine Combination Therapy
• 6.9. Global Dementia Treatment Market, Sub-Segmentation Of Other Treatment Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Enhancers
• NMDA Receptor Antagonists
• Nutritional And Herbal Supplements
• Hormonal Treatments
• Stem Cell Therapy

7. Dementia Treatment Market Regional And Country Analysis

• 7.1. Global Dementia Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Dementia Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Dementia Treatment Market

• 8.1. Asia-Pacific Dementia Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Dementia Treatment Market

• 9.1. China Dementia Treatment Market Overview
• 9.2. China Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Dementia Treatment Market

• 10.1. India Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Dementia Treatment Market

• 11.1. Japan Dementia Treatment Market Overview
• 11.2. Japan Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Dementia Treatment Market

• 12.1. Australia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Dementia Treatment Market

• 13.1. Indonesia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Dementia Treatment Market

• 14.1. South Korea Dementia Treatment Market Overview
• 14.2. South Korea Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Dementia Treatment Market

• 15.1. Western Europe Dementia Treatment Market Overview
• 15.2. Western Europe Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Dementia Treatment Market

• 16.1. UK Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Dementia Treatment Market

• 17.1. Germany Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Dementia Treatment Market

• 18.1. France Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Dementia Treatment Market

• 19.1. Italy Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Dementia Treatment Market

• 20.1. Spain Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Dementia Treatment Market

• 21.1. Eastern Europe Dementia Treatment Market Overview
• 21.2. Eastern Europe Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Dementia Treatment Market

• 22.1. Russia Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Dementia Treatment Market

• 23.1. North America Dementia Treatment Market Overview
• 23.2. North America Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Dementia Treatment Market

• 24.1. USA Dementia Treatment Market Overview
• 24.2. USA Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Dementia Treatment Market

• 25.1. Canada Dementia Treatment Market Overview
• 25.2. Canada Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Dementia Treatment Market

• 26.1. South America Dementia Treatment Market Overview
• 26.2. South America Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Dementia Treatment Market

• 27.1. Brazil Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Dementia Treatment Market

• 28.1. Middle East Dementia Treatment Market Overview
• 28.2. Middle East Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Dementia Treatment Market

• 29.1. Africa Dementia Treatment Market Overview
• 29.2. Africa Dementia Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Dementia Treatment Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Dementia Treatment Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Dementia Treatment Market Competitive Landscape And Company Profiles

• 30.1. Dementia Treatment Market Competitive Landscape
• 30.2. Dementia Treatment Market Company Profiles
  • 30.2.1. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Amgen Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Dementia Treatment Market Other Major And Innovative Companies

• 31.1. Biogen Inc.
• 31.2. Eisai Co. Ltd.
• 31.3. Merz Pharmaceuticals GmbH
• 31.4. Acadia Pharmaceuticals Inc.
• 31.5. Intra-Cellular Therapies Inc.
• 31.6. Cerevance Inc.
• 31.7. Retro Biosciences Inc.
• 31.8. AviadoBio Ltd.
• 31.9. MapHabit Inc.
• 31.10. Neuvivo Inc.
• 31.11. Harmonic Health Inc.
• 31.12. Rippl Care Inc.
• 31.13. Isaac Health Inc.
• 31.14. EmTech Care Labs Inc.
• 31.15. LifeBio Inc.

32. Global Dementia Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dementia Treatment Market

34. Recent Developments In The Dementia Treatment Market

35. Dementia Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Dementia Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Dementia Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Dementia Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer